
Entropix is an early-stage enzyme engineering company specializing in the directed evolution of high-performance enzymes and biocatalysts. Their protein engineering platform combines state-of-the-art experimental molecular technology and computational methods. The company's mission is to use directed evolution to develop novel enzymes that address challenges in diagnostic, life science, manufacturing, pharmaceutical, and food ingredient sectors, contributing to a sustainable economy. Their technology involves protein engineering, computational gene sequence analysis, enzyme structure analysis, and machine learning. Entropix has developed NADA™ and ALGO™ technologies for nucleic acid purification and is developing proprietary enzymes for sectors like plastics degradation and diagnostics. They are based in Cheshire, UK, and have received investment from LYVA Labs.

Entropix is an early-stage enzyme engineering company specializing in the directed evolution of high-performance enzymes and biocatalysts. Their protein engineering platform combines state-of-the-art experimental molecular technology and computational methods. The company's mission is to use directed evolution to develop novel enzymes that address challenges in diagnostic, life science, manufacturing, pharmaceutical, and food ingredient sectors, contributing to a sustainable economy. Their technology involves protein engineering, computational gene sequence analysis, enzyme structure analysis, and machine learning. Entropix has developed NADA™ and ALGO™ technologies for nucleic acid purification and is developing proprietary enzymes for sectors like plastics degradation and diagnostics. They are based in Cheshire, UK, and have received investment from LYVA Labs.